Aligos Therapeutics
Aligos Therapeutics focuses on developing targeted therapies for MASH and viral diseases using small molecule and oligonucleotide platforms. The company operates in South San Francisco, Leuven, and Shanghai, and is committed to diversity, equity, and inclusion.
Services
Aligos Therapeutics focuses on developing targeted therapies for MASH (metabolic dysfunction-associated steatohepatitis) and viral diseases. The company leverages small molecule and oligonucleotide platforms to identify new drug candidates. They are deeply engaged in the discovery and development of drug candidates targeting clinically validated mechanisms of action in MASH and viral diseases.
Global Offices
Aligos Therapeutics operates offices in three global locations: South San Francisco, California; Leuven, Belgium; and Shanghai, China. These offices support their worldwide research and development activities, allowing for a broad and diverse approach to their work in developing targeted therapies.
Research and Development Pipeline
Aligos Therapeutics has a robust pipeline of potentially best-in-class drug candidates for chronic liver diseases and viral infections, including MASH, chronic hepatitis B (CHB), and coronavirus. Their pipeline leverages small molecule and oligonucleotide platforms to identify and develop these therapeutic candidates. The company has presented clinical data at various scientific conferences such as ESCMID, APASL, HEP DART, AASLD, SITC, and EASL.
Funding and Collaborations
Aligos Therapeutics has received more than $12 million in funding from the NIH and NIAID’s AViDD Centers for Pathogens of Pandemic Concern program through the MAVDA consortium. Additionally, they have been awarded an NIAID Contract, supporting their ongoing research and development efforts in addressing significant medical needs in the areas of chronic liver diseases and viral infections.
Work Culture and Employee Benefits
Aligos Therapeutics maintains a science-first, data-driven culture within a highly-collaborative, fast-paced environment. The company promotes a hybrid work philosophy that combines face-to-face collaboration with remote work options. They offer comprehensive employee benefits, including medical, dental, and vision insurance, paid holidays, year-end holiday closure, paid time off, and new parent leave. Other benefits include a pension plan, 401(k) with employer match, employee stock purchase plan, equity compensation, transit and parking FSA, a company car for eligible employees, career development opportunities, meal subsidy, and a dog-friendly workplace. Aligos Therapeutics is also dedicated to diversity, equity, and inclusion.